Gut Microbiota Manipulation in Irritable Bowel Syndrome
Author:
Open Access
- 30 June 2022
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 10 (7) , 1332
Abstract
Increased knowledge suggests that disturbed gut microbiota, termed dysbiosis, might promote the development of irritable bowel syndrome (IBS) symptoms. Accordingly, gut microbiota manipulation has evolved in the last decade as a novel treatment strategy in order to improve IBS symptoms. In using different approaches, dietary management stands first in line, including dietary fiber supplements, prebiotics, and probiotics that are shown to change the composition of gut microbiota, fecal short-chain fatty acids and enteroendocrine cells densities and improve IBS symptoms. However, the exact mixture of beneficial bacteria for each individual remains to be identified. Prescribing nonabsorbable antibiotics still needs confirmation, although using rifaximin has been approved for diarrhea-predominant IBS. Fecal microbiota transplantation (FMT) has recently gained a lot of attention, and five out of seven placebo-controlled trials investigating FMT in IBS obtain promising results regarding symptom reduction and gut microbiota manipulation. However, more data, including larger cohorts and studying long-term effects, are needed before FMT can be regarded as a treatment for IBS in clinical practice.Keywords
This publication has 102 references indexed in Scilit:
- The Effect of a Multispecies Probiotic Mixture on the Symptoms and Fecal Microbiota in Diarrhea-dominant Irritable Bowel SyndromeJournal of Clinical Gastroenterology, 2012
- Functional dysbiosis within the gut microbiota of patients with constipated‐irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2012
- Cesarean Versus Vaginal Delivery: Long-term Infant Outcomes and the Hygiene HypothesisClinics in Perinatology, 2011
- The Role of Genetics in IBSGastroenterology Clinics of North America, 2011
- A human gut microbial gene catalogue established by metagenomic sequencingNature, 2010
- Diarrhoea-predominant irritable bowel syndromedistinguishable by 16S rRNA gene phylotype quantifcationWorld Journal of Gastroenterology, 2009
- Mode of Delivery – Effects on Gut Microbiota and Humoral ImmunityNeonatology, 2007
- Perceived food intolerance in subjects with irritable bowel syndrome – etiology, prevalence and consequencesEuropean Journal of Clinical Nutrition, 2005
- Inflammation as a basis for functional GI disordersBest Practice & Research Clinical Gastroenterology, 2004
- Effects of fructo‐oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humansNutrition and Cancer, 1996